Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02260440
Title A Phase 2 Study of MK-3475 in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Pittsburgh
Indications

colorectal cancer

Therapies

Azacitidine + Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.